BioCryst Pharmaceuticals is a startup based in the United States, 1 tracked investor.
Based in the United States, BioCryst Pharmaceuticals is a startup. Brouky records 1 investor associated with the company.
BioCryst Pharmaceuticals is a global biotechnology company focused on discovering, developing, and commercializing oral small-molecule and injectable protein therapeutics for rare diseases, including hereditary angioedema (HAE).
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.